The nation of Zimbabwe has rejected a major US health deal valued at $367m (£272m) spanning five years due to Washington's insistence on confidential data.
The decision was revealed after a official document from December was leaked, which showed President Emmerson Mnangagwa believed the deal was "unbalanced".
An official spokesperson later explained that the United States was seeking health data for scientific study and profit while was unwilling to guarantee the benefits from any future medical innovations.
"We are forced to start the challenging and unfortunate process of winding down our support in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy said the United States had provided over $1.9bn in health funding to Zimbabwe over the last twenty years.
A doctors' association in Zimbabwe has appealed for more dialogue to secure a deal acceptable to all parties so the nation's vital HIV programme can proceed.
Broader Background
This development follows a similar case in Kenya, where a high court blocked a related health funding agreement following concerns were raised about the safety of Kenyans' medical information.
Since resuming the presidency last year, US President Donald Trump has drastically cut overseas assistance and shut down the key foreign aid agency.
USAID had administered aid for the American government, but Trump stated its expenditure was "inefficient" and his administration was seeking direct bilateral agreements to boost transparency and accountability.
According to statements, Sixteen nations in Africa have so far agreed to these new agreements, representing more than $18.3bn of fresh investment.
Specifics of the Declined Deal
The money for Zimbabwe was intended to funded "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"We believe this cooperation might have yielded significant benefits for the people of Zimbabwe, particularly the 1.2 million men, women and children presently receiving antiretroviral therapy through US-supported initiatives," Tremont said.
However, government spokesperson Nick Mangwana said the arrangement was "unfair".
"The proposal required Zimbabwe to provide its biological resources and data for a long time, with no equivalent promise of benefiting from any medical innovations – such as new medicines or tests – that could result from that shared data," his statement read.
"In essence, our nation would provide the basic resources for medical research without any certainty that the final treatments would be accessible to our citizens if a new pandemic emerge."
National Interest and Global Health
Mangwana further said that the US's withdrawal from the World Health Organization (WHO) and its push of one-on-one deals were undermining systems previously set up through the international health agency.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing scheme designed to manage potential pandemics.
"This system is intended to guarantee that when a country provides its data, the resulting advantages – such as medicines and cures – are shared equitably, not commercialised exclusively by those with the funds to create them."
These objections over the US deal "must not be interpreted as anti-American sentiment," Mangwana stressed.
"We welcome continued dialogue with our American counterparts on how subsequent co-operation could be arranged in a way that respects the independence and interests of each country."
Health Experts Reaction
A leading public health body said it acknowledged the government's concerns, but recommended that talks must proceed considering a large portion of the country's HIV programmes were funded by international support.
"If specific concerns exist, such as those involving data governance or implementation frameworks, these can often be resolved via technical clarification and mutually agreed protections," it commented.
This impasse highlights the ongoing debate between receiving vital foreign assistance and protecting a country's data in an increasingly interconnected world.